Becotatug vedotin
Based on 1 Customer Validation
Becotatug vedotin (MRG003) is an Antibody-Drug Conjugate (ADC) that consists of an anti-EGFR humanized IgG1 monoclonal antibody Becotatug (HY-P990049) and MMAE (HY-15162). These two parts are connected through a valine-citrulline (valine-citrulline) linker, where the linker and MMAE constitute the ADC's Drug-Linker conjugate VcMMAE (HY-15575). Becotatug vedotin is also an inhibitor of tubulin, which can be used for the research of cancer, such as squamous cell carcinomas of the head and neck, nasopharyngeal carcinoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度 : 96.99%
- 分子量:149470 (average)
-
保管条件:Shipping with dry ice
-80°C, protect from light
生物活性
製品説明
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
臨床実験
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Product Details
化学情報
-
性状 Liquid
-
分子量 149470 (average)
-
Color Colorless to light yellow
-
SMILES
[Becotatug vedotin]
-
別名
MRG003
-
輸送条件
Shipping with dry ice.
-
保管条件
-80°C, protect from light
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Becotatug vedotin
- MRG003
- MRG 003
- MRG-003
- Antibody-Drug Conjugates (ADCs)
- EGFR
- Antibody-Drug Conjugates
- ADC
- Epidermal growth factor receptor
- ErbB-1
- HER1
- monomethyl auristatin E
- nasopharyngeal carcinoma
- squamous cell carcinomas of the head and neck
- valine-citrulline linker
- epidermal growth factor receptor
- humanized immunoglobulin G1 monoclonal antibody
- Inhibitor
- inhibitor
- inhibit